AJMC August 22, 2023
Dr. Stephen Kingsmore shares the exciting advancement of the BeginNGS newborn genomic sequencing program as it approaches the end of phase 2.
Stephen Kingsmore, MD, DSc, president and CEO, at Rady Children’s Institute for Genomic Medicine, details the progression of the BeginNGS newborn genomic sequencing program as it approaches the end of phase 2. He explains the basis of phase 1 consisted of determining the program’s feasibility and also how it will be expanded in phase 3.
Transcript
Can you discuss phase 1 & 2 of the BeginNGS program and the significance of adding to the newborn genomic sequencing?
Yes, about a year ago, we were just finishing phase 1 and that was pure research. “Could this be done?” was...
Today's Sponsors
Today's Sponsor